Characterization of N1- and N6-adenosine adducts and N1-inosine adducts formed by the reaction of butadiene monoxide with adenosine: Evidence for the N1-adenosine adducts as major initial products

Chemical Research in Toxicology

Volumn 9, Issue 5, 1996, Pages 875-881

  Selzer, Rebecca R ^a   Elfarra, Adnan A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ADENOSINE; ADENOSINE DERIVATIVE; INOSINE DERIVATIVE; 1,2 EPOXY 3 BUTENE; 3,4-EPOXY-1-BUTENE; DRUG DERIVATIVE; EPOXIDE; INOSINE; MUTAGENIC AGENT; N(6) RIBOSYLADENINE; N(6)-RIBOSYLADENINE;

ARTICLE; CARCINOGENICITY; CIGARETTE SMOKING; DEAMINATION; EXHAUST GAS; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; MUTAGENICITY; PETROCHEMICAL INDUSTRY; PLASTIC INDUSTRY; PROTON NUCLEAR MAGNETIC RESONANCE; RUBBER INDUSTRY; ULTRAVIOLET SPECTROPHOTOMETRY; CHEMISTRY; DNA ADDUCT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADENOSINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; EPOXY COMPOUNDS; INOSINE; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MUTAGENS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0029662162     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960039a     Document Type: Article

References (20)

1. Melnick, R. L., Huff, J., Chou, B. J., and Miller, R. A. (1990) Carcinogenicity of 1,3-butadiene in C57BL/6 × CH3 F1 mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
2. Owen, P. E., Glaister, J. R., Gaunt, I. F., and Pullinger, D. H. (1987) Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
3. Santos-Burgoa, C., Matanoski, G. M., Zeger, S., and Schwartz, L. (1992) Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am. J. Epidemiol. 136, 843-854.
4. Ward, J. B., Ammenheuser, M. M., Bechtold, W. E., Whorton, E. B., and Legator, M. S. (1994) hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ. Health Perspect. 102 (Suppl. 9), 79-85.
5. Bolt, H. M., Schmiedel, G., Gilser, J. G., Rolzhauser, H. P., Lieser, K., Wistuba, D., and Schurig, V. (1983) Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol. 106, 112-116.
6. Elfarra, A. A., Duescher, R. J., and Pasch, C. M. (1991) Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase. Arch. Biochem. Biophys. 286, 244-251.
7. Sharer, J. E., Duescher, R. J., and Elfarra, A. A. (1992) Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Possible role in 1,3-butadiene-induced toxicity. Drug Metab. Dispos. 20, 658-664.
8. Duescher, R. J., and Elfarra, A. A. (1992) 1,3-Butadiene oxidation by human myeloperoxidase. Role of chloride ion in catalysis of divergent pathways. J. Biol. Chem. 267, 19859-19865.
9. Duescher, R. J., and Elfarra, A. A. (1994) Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342-349.
10. de Meester, C., Poncelet, F., Roberfroid, M., and Mercier, M. (1978) Mutagenicity of butadiene and butadiene monoxide. Biochem. Biophys. Res. Commun. 80, 298-305.
11. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene, and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15, 719-723.
12. 7-guanosine adducts of butadiene monoxide. Chem. Res. Toxicol. 9, 126-132.
13. Selzer, R. R., and Elfarra, A. A. (1995) Characterization of adenosine and guanosine adducts of butadiene monoxide. Toxicologist 15, 76.
14. 1-inosine adducts of butadiene monoxide. Fundam. Appl. Toxicol. (Suppl.) 30, 233.
15. Singer, B., and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens, Plenum Press, New York.
16. Fujii, R., Saito, R., and Terahara, N. (1986) Purines. XXVII. Hydrolytic deamination versus Dimroth rearrangement in the 9-substituted purine ring: Effect of an omega-hydroxyalkyl group at the 1-position. Chem. Pharm. Bull. 34, 1094-1107.
17. Sadtler Research Laboratories Inc. Standard Proton NMR Collection (1978) Philadelphia, PA. Spectra 27540M.
18. 6-positions. Chem. Res. Toxicol. 8, 289-395.
19. Moore, P. D., Koreeda, M., Wislocki, P. G., Levin, W., Conney, A. H., Yagi, H., and Jerina, D. M. (1977) In vitro reactions of the diastereomeric 9,10-epoxides of (+) and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene with polyguanylic acid and evidence for formation of an enantiomer of each diastereomeric 9,10-epoxide from benzo[a]pyrene on mouse skin. In Drug Metabolism Concepts (Jerina, D. M., Ed.) ACS Symposium Series No. 44, pp 127-154, American Chemical Society, Washington, DC.
20. 6-adenine adducts. Carcinogenesis 16, 2999-3007.